Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy

Research output: Contribution to journalReview article

Abstract

Epigenetic modifications modulate chromatin states to regulate gene expression. Among them, DNA methylation and histone modifications play a crucial role in the establishment of the epigenome. In cancer, these epigenetic events may act in concert to repress tumor suppressor genes or promote oncogenic pathways. In the context of cancer initiation and progression, recruitment of DNA (cytosine-5)-methyltransferases to specific genomic regions is mainly mediated by histone epigenetic marks, transcription factors and co-regulators as part of a dynamic process. Herein, we will review these mechanisms and present state-of-the-art of DNA methylation, treatment and development of epigenetic cancer therapies targeting this epigenetic modification.
Original languageEnglish
Article number139
Pages (from-to)137-147
Number of pages11
JournalBiochimie
Volume139
DOIs
Publication statusPublished - 1 Aug 2017

Fingerprint

DNA (Cytosine-5-)-Methyltransferase
Epigenomics
Histones
Histone Code
Gene expression
Chromatin
Tumors
DNA Methylation
Neoplasms
Transcription Factors
Genes
Therapeutics
Tumor Suppressor Genes
Gene Expression

Keywords

  • DNA methylation
  • Promoter methylation
  • Gene body methylation
  • protein-protein interaction
  • DNMT inhibitors
  • Epigenetic therapy
  • Protein-protein interaction

Cite this

@article{4418692258b54bc5aee3a7247b55b249,
title = "Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy",
abstract = "Epigenetic modifications modulate chromatin states to regulate gene expression. Among them, DNA methylation and histone modifications play a crucial role in the establishment of the epigenome. In cancer, these epigenetic events may act in concert to repress tumor suppressor genes or promote oncogenic pathways. In the context of cancer initiation and progression, recruitment of DNA (cytosine-5)-methyltransferases to specific genomic regions is mainly mediated by histone epigenetic marks, transcription factors and co-regulators as part of a dynamic process. Herein, we will review these mechanisms and present state-of-the-art of DNA methylation, treatment and development of epigenetic cancer therapies targeting this epigenetic modification.",
keywords = "DNA methylation, Promoter methylation, Gene body methylation, protein-protein interaction, DNMT inhibitors, Epigenetic therapy, Protein-protein interaction",
author = "Gr{\'e}goire Rondelet and Johan Wouters",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.biochi.2017.06.003",
language = "English",
volume = "139",
pages = "137--147",
journal = "Biochimie",
issn = "0300-9084",
publisher = "Elsevier",

}

TY - JOUR

T1 - Human DNA (cytosine-5)-methyltransferases

T2 - a functional and structural perspective for epigenetic cancer therapy

AU - Rondelet, Grégoire

A2 - Wouters, Johan

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Epigenetic modifications modulate chromatin states to regulate gene expression. Among them, DNA methylation and histone modifications play a crucial role in the establishment of the epigenome. In cancer, these epigenetic events may act in concert to repress tumor suppressor genes or promote oncogenic pathways. In the context of cancer initiation and progression, recruitment of DNA (cytosine-5)-methyltransferases to specific genomic regions is mainly mediated by histone epigenetic marks, transcription factors and co-regulators as part of a dynamic process. Herein, we will review these mechanisms and present state-of-the-art of DNA methylation, treatment and development of epigenetic cancer therapies targeting this epigenetic modification.

AB - Epigenetic modifications modulate chromatin states to regulate gene expression. Among them, DNA methylation and histone modifications play a crucial role in the establishment of the epigenome. In cancer, these epigenetic events may act in concert to repress tumor suppressor genes or promote oncogenic pathways. In the context of cancer initiation and progression, recruitment of DNA (cytosine-5)-methyltransferases to specific genomic regions is mainly mediated by histone epigenetic marks, transcription factors and co-regulators as part of a dynamic process. Herein, we will review these mechanisms and present state-of-the-art of DNA methylation, treatment and development of epigenetic cancer therapies targeting this epigenetic modification.

KW - DNA methylation

KW - Promoter methylation

KW - Gene body methylation

KW - protein-protein interaction

KW - DNMT inhibitors

KW - Epigenetic therapy

KW - Protein-protein interaction

UR - http://www.scopus.com/inward/record.url?scp=85020750618&partnerID=8YFLogxK

U2 - 10.1016/j.biochi.2017.06.003

DO - 10.1016/j.biochi.2017.06.003

M3 - Review article

VL - 139

SP - 137

EP - 147

JO - Biochimie

JF - Biochimie

SN - 0300-9084

M1 - 139

ER -